Advertisement

Spinal Tech

Advertisement

Carlsmed raised $30 million in series B funding to ramp up commercialization of its personalized spine implants, the devicemaker said April 19.

Accelus, a minimally invasive spine device company, and CHP Merger Corp., a special purpose acquisition company, have terminated a previously agreed-upon merger of the companies because of market conditions.

Advertisement